EU likely to decline new vaccine deals with Astrazeneca and J&J

The EU is negotiating with Pfizer/Biontech and Moderna for new vaccine contracts, states French economy minister, but it's unlikely the union it will reach out to Astrazeneca or Johnson & Johnson.
Photo: Dado Ruvic/REUTERS / X02714
Photo: Dado Ruvic/REUTERS / X02714
BY RITZAU, TRANSLATED BY NIELSINE NIELSEN

It improbable that the EU will renew its vaccine contract with British-Swedish Astrazeneca, and no negotiations have been entered into with US giant Johnson & Johnson either, says Secretary of State for Economy and Finance Agnes Pannier-Runacher, according to news agency AFP.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading